1. Dang, Hien, Pomyen, Yotsawat, Martin, Sean P, Bodzin, Adam S, Wang, Xin Wei. 2019. NELFE-Dependent MYC Signature Identifies a Unique Cancer Subtype in Hepatocellular Carcinoma. In Scientific reports, 9, 3369. doi:10.1038/s41598-019-39727-9. https://pubmed.ncbi.nlm.nih.gov/30833661/
2. Yu, Shijun, Li, Li, Cai, Hui, Gao, Yong, Li, Yandong. 2021. Overexpression of NELFE contributes to gastric cancer progression via Wnt/β-catenin signaling-mediated activation of CSNK2B expression. In Journal of experimental & clinical cancer research : CR, 40, 54. doi:10.1186/s13046-021-01848-3. https://pubmed.ncbi.nlm.nih.gov/33526068/
3. Zhang, Jieqiong, Hu, Zhenhua, Chung, Hwa Hwa, Tan, Ern Yu, Tee, Wee-Wei. 2023. Dependency of NELF-E-SLUG-KAT2B epigenetic axis in breast cancer carcinogenesis. In Nature communications, 14, 2439. doi:10.1038/s41467-023-38132-1. https://pubmed.ncbi.nlm.nih.gov/37117180/
4. Han, Lili, Zan, Ying, Huang, Chen, Zhang, Shuqun. 2019. NELFE promoted pancreatic cancer metastasis and the epithelial‑to‑mesenchymal transition by decreasing the stabilization of NDRG2 mRNA. In International journal of oncology, 55, 1313-1323. doi:10.3892/ijo.2019.4890. https://pubmed.ncbi.nlm.nih.gov/31638184/
5. Schott, Geraldine, Garcia-Blanco, Mariano A. 2020. MHC Class III RNA Binding Proteins and Immunity. In RNA biology, 18, 640-646. doi:10.1080/15476286.2020.1860388. https://pubmed.ncbi.nlm.nih.gov/33280511/
6. Santaliz-Casiano, Ashlie, Mehta, Dhruv, Danciu, Oana C, Hoskins, Kent F, Madak-Erdogan, Zeynep. 2023. Identification of metabolic pathways contributing to ER+ breast cancer disparities using a machine-learning pipeline. In Scientific reports, 13, 12136. doi:10.1038/s41598-023-39215-1. https://pubmed.ncbi.nlm.nih.gov/37495653/
智鼠故事 
